 |
2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
|---|---|
| Trade Name | |
| Orphan Indication | Sickle cell anemia |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | SynteractHCR Deutschland GmbH |
Related Access Program
| |
2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
|---|---|
| Trade Name | |
| Orphan Indication | Sickle cell anemia |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | SynteractHCR Deutschland GmbH |